Novant Health Clinical Research provides access to a variety of cardiac research
Study Name/Number: Respicardia
Title: Respicardia, Inc. Pivotal Trial of the remedē System
Investigator: Michael Drucker, MD
Purpose: A randomized trial evaluating the safety and effectiveness of the remedē system in patients with Central Sleep Apnea The purpose of this prospective, multicenter, randomized trial is to evaluate the safety and effectiveness of therapy delivered by the remedē system in subjects with moderate to severe CSA and optimal medical management, compared to outcomes in randomized control subjects receiving optimal medical management and implanted but inactive remedē systems.
Eligibility: At least 18 years old, central sleep apnea, medically stable
Linkto the current ClinicalTrials.gov record »